Multivalent group A streptococcal vaccine designed to optimize the immunogenicity of six tandem M protein fragments

By Dale J.B.  

Vaccine, Vol. 17, Iss. 2, 1999-01 ,pp. : 193-200

Elsevier

Access to resources Recommend Favorite

Parenteral and mucosal delivery of a novel multi-epitope M protein-based group A streptococcal vaccine construct: investigation of immunogenicity in mice

By Dunn L.A.   McMillan D.J.   Batzloff M.   Zeng W.   Jackson D.C.J.   Upcroft J.A.   Upcroft P.   Olive C.  

Vaccine, Vol. 20, Iss. 21, 2002-06 ,pp. : 2635-2640

Elsevier

Access to resources Recommend Favorite

Protection of mice from group A streptococcal infection by intranasal immunisation with a peptide vaccine that contains a conserved M protein B cell epitope and lacks a T cell autoepitope

By Olive C.   Clair T.   Yarwood P.   Good M.F.  

Vaccine, Vol. 20, Iss. 21, 2002-06 ,pp. : 2816-2825

Elsevier

Access to resources Recommend Favorite

Evaluation of synthetic, M type-specific peptides as antigens in a multivalent group A streptococcal vaccine

By Bruner M.   James A.   Beall B.   Carlone G.M.   Ades E.   Johnson S.   Guarner J.   Sampson J.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 2698-2703

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a tetravalent group B streptococcal polysaccharide vaccine in healthy adults

By Kotloff K.L.   Fattom A.   Basham L.   Hawwari A.   Harkonen S.   Edelman R.  

Vaccine, Vol. 14, Iss. 5, 1996-04 ,pp. : 446-450

Elsevier

Access to resources Recommend Favorite